Immediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque Psoriasis
Phase of Trial: Phase IV
Latest Information Update: 08 Mar 2013
At a glance
- Drugs Adalimumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Abbott Laboratories
- 07 Jun 2017 Biomarkers information updated
- 11 May 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.
- 11 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.